Zobrazeno 1 - 10
of 31
pro vyhledávání: '"59"'
Autor:
Xavier Fung, I.Chuan Li, Kandiah Chandrakumaran, Tom Cecil, Sanjeev Dayal, Alexios Tzivanakis, Brendan Moran, Faheez Mohamed
Publikováno v:
European Journal of Surgical Oncology. 48:1614-1618
There is ongoing controversy concerning the indications and benefits of early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with pseudomyxoma
Autor:
Tunc Guler, Yuksel Urun, Huseyin Abali, Nurullah Zengin, Berna Oksuzoglu, Gülsüm Özet, Burcin Budakoglu, Nuriye Yildirim
Publikováno v:
Cancer Investigation. 26:401-406
Background: High dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) is currently the treatment of choice for relapsed or refractory lymphoma patients. However, the optimal salvage regimen for these patients is unclear. In this
Autor:
Jan C. Peeken, Benjamin Schlossmacher, Florian Lenze, Ulrich Lenze, Ruediger von Eisenhart-Rothe, Stephanie E. Combs, Alexandra S. Gersing, Rainer Burgkart, Heinrich M L Muehlhofer, Carolin Knebel
Publikováno v:
Anticancer Research. 41:359-368
BACKGROUND/AIM Surgical resection for soft tissue sarcomas (STSs) is the gold standard for a curative oncologic therapy in combination with neoadjuvant or adjuvant radiation therapy (NRT/ART). The aim of this study was to determine prognostic factors
Autor:
Sebastian F. Schoppmann, Ana-Iris Schiefer, Matthias Preusser, Hossein Taghizadeh, Aysegül Ilhan-Mutlu, Renate Kain, Alexander K Karner, Hannah Christina Puhr, Andrea Beer, Gerd Jomrich
Publikováno v:
Pathology Oncology Research
Immunotherapy with check-point inhibitors serves as a promising treatment strategy in patients with upper gastrointestinal (GI) tumors. Human epidermal growth factor receptor 2 (HER2) is the only identified therapeutic target in upper GI tumors, whos
Autor:
Simonetta Bianchi, Irene Renda, Milo Giani, Tommaso Susini, Ketty Tavella, A. Villanucci, Ermanno Vanzi, Arianna Vallario, Jacopo Nori
Publikováno v:
Anticancer Research. 40:1079-1085
Background/aim We evaluated the efficacy of neoadjuvant chemotherapy (NACT) in reducing locally-advanced breast cancer (LABC) size, thus improving breast-conserving surgery (BCS) rates, as well as its long-term outcome. Patients and methods We analyz
Autor:
Nobuhiro Tsukada, Shin-ichi Fuchida, Satoshi Yoshioka, Tatsuo Oyake, Yoshinobu Kanda, Keisuke Kataoka, Noriko Doki, Tatsuo Ichinohe, Hiroyuki Takamatsu, Shinichi Kako, Emiko Sakaida, Shinsuke Iida, Shohei Mizuno, Yoshiko Astuta, Mitsuhiro Itagaki, Yutaka Shimazu, Kazuhito Suzuki, Akira Hanagaishi
Publikováno v:
Cancer Science
New drugs for multiple myeloma (MM) have dramatically improved patients’ overall survival (OS). Autologous stem cell transplantation (ASCT) remains the mainstay for transplant‐eligible MM patients. To investigate whether the post‐ASCT prognosis
Autor:
Omer Aziz, C. Lavelle, Malcolm S Wilson, T. Evans, Sarah T O'Dwyer, Lee Malcomson, Bipasha Chakrabarty
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 47(1)
Introduction Low grade appendiceal mucinous neoplasms (LAMN) are known to metastasise to the peritoneum resulting in pseudomyxoma peritonei (PMP). Literature suggests that the long-term outcome is dependent on the cellular grade of the peritoneal his
Publikováno v:
Acta Oncologica. 57:1209-1215
Standard treatment of localized squamous cell carcinoma of the anus (SCCA) is radiotherapy (RT) combined with chemotherapy, that is, chemoradiation (CRT). Primary surgery has a limited role, but is a recommended treatment for small well differentiate
Autor:
Makoto Tahara, Minoru Sakuraba, Naoki Nakamura, Takaki Ariji, Atsushi Motegi, Sunao Tokumaru, Mitsuhiko Kawashima, Tetsuo Akimoto, Mitsutoshi Ooishi, Sadamoto Zenda, Satoko Arahira, Ryuichi Hayashi
Publikováno v:
Japanese Journal of Clinical Oncology. 46:919-927
OBJECTIVE To evaluate the feasibility of postoperative intensity-modulated radiotherapy for head and neck cancer by investigating the patterns of failure after this therapy. METHODS A retrospective chart review was performed. RESULTS Between March 20
Publikováno v:
JAMA oncology. 4(10)
IMPORTANCE: There is limited information on the association among complementary medicine (CM), adherence to conventional cancer treatment (CCT), and overall survival of patients with cancer who receive CM compared with those who do not receive CM. OB